Bristol Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Alleging Intentional Delay of Cancer Drug
U.S. District Judge Jesse Furman dismissed the action, finding plaintiff was never properly appointed as successor-trustee and therefore was unable to bring the suit on behalf of shareholders.
October 01, 2024 at 04:45 PM
3 minute read
PharmaceuticalsA New York federal judge has dismissed a $6.4 billion lawsuit against Bristol Myers Squibb, agreeing with counsel for the pharmaceutical company that plaintiffs lacked subject matter jurisdiction.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllBristol Myers Urges Dismissal of $6.4 Billion Lawsuit, Arguing Lack of Subject Matter Jurisdiction
Class Action Against Equity Crowdfunder Over Misleading Emails Moves Forward
Abbott Laboratories Wins Bid to Freeze Trusts of Defendants Accused of Evading Judgment
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2How I Made Office Managing Partner: 'If You Are Aware of Areas for Improvement and You Can Play a Role in That, Speak Up,' Says Jennifer Mellott of Freshfields
- 3'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5Burns & Levinson to Wind Down After 64 Years in Boston
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250